Biocon added 1.36% to Rs 325.25 after the company announced that its subsidiary, Biocon Biologics (BBL), has launched YESINTEK (ustekinumab-kfce) in the United States.

Extreme heat is leading to a rise in a range of mental health and social issues. Experts say its effects need to be taken ...

A study from Kuwait's Dasman Diabetes Institute reveals alarming insights into the effects of sleep deprivation on the immune system. Here are key takeaways.

The Medicines and Healthcare Products Regulatory Agency (MHRA) revealed in association with the use of GLP-1RA receptor agonist drugs such as Mounjaro, Wegovy and Ozempic, up to January 31.